Long-term Efficacy and Safety of Erenumab: Results From 64 Weeks of the LIBERTY Study.
Goadsby PJ, Reuter U, Lanteri-Minet M, Paiva da Silva Lima G, Hours-Zesiger P, Fernandes C, Wen S, Tenenbaum N, Kataria A, Ferrari MD, Klatt J.
Goadsby PJ, et al. Among authors: hours zesiger p.
Neurology. 2021 May 31;96(22):e2724-e2735. doi: 10.1212/WNL.0000000000012029.
Neurology. 2021.
PMID: 33910942
Free PMC article.